Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study

  1. Berger, S.P.
  2. Sommerer, C.
  3. Witzke, O.
  4. Tedesco, H.
  5. Chadban, S.
  6. Mulgaonkar, S.
  7. Qazi, Y.
  8. de Fijter, J.W.
  9. Oppenheimer, F.
  10. Cruzado, J.M.
  11. Watarai, Y.
  12. Massari, P.
  13. Legendre, C.
  14. Citterio, F.
  15. Henry, M.
  16. Srinivas, T.R.
  17. Vincenti, F.
  18. Gutierrez, M.P.H.
  19. Marti, A.M.
  20. Bernhardt, P.
  21. Pascual, J.
Revue:
American Journal of Transplantation

ISSN: 1600-6143,  1600-6135

Année de publication: 2019

Volumen: 19

Número: 11

Pages: 3018-3034

Type: Article

DOI: 10.1111/AJT.15480 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus